about
Systemic hypertension and glaucoma: mechanisms in common and co-occurrenceApparent mineralocorticoid excess syndrome: an overviewAdiponectin deficiency, diastolic dysfunction, and diastolic heart failure.Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism.Matching the right drug to the right patient in essential hypertensionThe pharmacological treatment of primary aldosteronism.Hypokalaemia: common things occur commonly - a retrospective survey.Renin: friend or foe?Antiaging Gene Klotho Regulates Adrenal CYP11B2 Expression and Aldosterone SynthesisAdrenocortical dysregulation as a major player in insulin resistance and onset of obesity.Differential aerobic exercise-induced changes in plasma aldosterone between African Americans and Caucasians.Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea hypopnea syndrome: effect of continuous positive airway pressure treatment.Neuroblastoma accompanied by hyperaldosteronism.Trends in the prevalence of primary aldosteronism, aldosterone-producing adenomas, and surgically correctable aldosterone-dependent hypertension.Aldosterone-to-renin ratio and home blood pressure in subjects with higher and lower sodium intake: the Ohasama study.Adrenocortical carcinoma producing 11-deoxycorticosterone: a rare cause of mineralocorticoid hypertension.The association between the renin-angiotensin-aldosterone system and arterial stiffness in young healthy subjects.Ectopic ACTH syndrome revealed as severe hypokalemia and persistent hypertension during the perioperative period: a case report.Primary hyperaldosteronism: a case of unilateral adrenal hyperplasia with contralateral incidentaloma.
P2860
Q24670423-78B6EABD-E506-4625-9BAC-D322496D3C3FQ28239329-9A865F34-0A6D-4BAD-BB76-439D50716F84Q33511929-A7A90CCE-2510-4DF2-B934-395AA62865F8Q33930728-65F4899A-DF69-4CC5-ADBF-77B131D646DDQ34284994-55A6AFDA-3693-4673-AEE1-DE54ACAB8289Q36428495-BA8963A7-D3CF-45BF-A523-6ED7D09B846CQ36533718-D0CC7CB4-7ED1-48F6-9AF6-0441ECB750BBQ36815446-F86DE713-60FC-4C37-B5BA-C16AE9967D06Q36944645-7AEFC32F-265A-4CBD-8563-BCA3A28AA561Q36958256-A78B0442-4729-4499-9145-519C72634E7DQ37311092-0E9433DF-3B74-4707-A869-06B2FC32979DQ37495691-0286F380-64F0-47CA-B8DC-7529BA3C3FE2Q40185721-E9CEEDC0-4282-41A1-BD13-EDCC6FEB8ED6Q44805596-D8BB481D-B951-40FD-AD4B-99113536ACF1Q45129805-B8E0F792-ED23-4CB5-9248-6AFDC03E3C0EQ46426597-50171674-E402-4721-9487-C88032A4A6A7Q46808674-9C054712-EA8C-4B32-A0ED-8341EBFFD908Q48313954-2CBC72A1-E1E8-4D44-99D5-81353B6A8291Q51490172-4E5A3D2F-DF38-4ECF-AC7B-07F2BA270480
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Mineralocorticoid hypertension.
@ast
Mineralocorticoid hypertension.
@en
type
label
Mineralocorticoid hypertension.
@ast
Mineralocorticoid hypertension.
@en
prefLabel
Mineralocorticoid hypertension.
@ast
Mineralocorticoid hypertension.
@en
P1433
P1476
Mineralocorticoid hypertension.
@en
P2093
P M Stewart
P304
P356
10.1016/S0140-6736(98)06102-9
P407
P577
1999-04-01T00:00:00Z